Page 14 - Flipbook

PERSISTANCE TO PHARMACOLOGICAL TREATMENTS TO OAB

• Persistence to pharmacological therapies after 1 year:

• Antimuscarinics: 12% to 25%

• Mirabegron: 32% to 38%

• Median time to discontinuation:

• Antimuscarinics: < 5 months

• Mirabegron: 5.6 to 7.4 months

Yeowell G, et al. BMJ Open 2018;8:e021889